TELA Bio, Inc. (TELA)
Nasdaq: TELA · Surgical & Medical Instruments & Apparatus · Malvern, PA · filing with the SEC since 2012
Filings
271 filings since 2017 beside 273 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by May 15, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 41 days after the quarter ended. The proxy statement was last filed Sep 14, 2026.
Filings a yearinsider forms included
56547411357626160
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Sep 18, 2026.Officer or director change (8-K item 5.02): 10 times in the last 36 months, the newest Aug 31, 2026.SEC letters: 3 in the last 36 months, the newest Dec 16, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Aug 31, 2026
8-K items 2.05, 5.02, 7.01, 9.01
Exit or restructuring costs; Officer or director change; Investor disclosure (Regulation FD) · Current report
Aug 28, 2026
Jun 11, 2026
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
Jun 9, 2026
May 12, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Apr 30, 2026
8-K items 2.02, 5.02
Results released; Officer or director change · Current report
Apr 29, 2026
Mar 24, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Nov 14, 2025
8-K items 1.01, 1.02, 2.03, 3.02, 9.01
Major agreement signed; Major agreement ended; New debt or obligation taken on; Shares sold without registration · Current report
Nov 13, 2025
40 of 271 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.